Clinical Trial

Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.

Study acronym: DEX
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This prospective, randomized, double-blind, placebo-controlled study to determine whether intrathecal dexmedetomidine, administered along with hyperbaric bupivacaine for covering Cesarean delivery decreases the incidence of shivering associated with spinal anesthesia
Trial Details
NCT Number NCT06942000
Lead Sponsor Al-Azhar University
Conditions Post Spinal Anesthesia Shivering
Enrollment 40 participants
Start Date 2025-05-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-24